Latest News

MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study

MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study
July 08, 2022

Radboud University Medical Center is Conducting Safety Evaluation of MediSieve’s Magnetic Haemofiltration System for the Treatment of Acute Hyperinflammation.
MediSieve at Industry Events In June 2022

MediSieve at Industry Events In June 2022
June 29, 2022

MediSieve, a London based biotech startup, has been busy presenting and demonstrating its technology at industry events as well as connecting with fellow scientists throughout June.
Copyright 2022 by MediSieve. Company number 8983823 registered in England and Wales. Registered address: 48 Chancery Lane, London, WC2A 1JF.
Terms of use | Privacy Policy |